Earnings Feed
Start Free
Home/Filings/4/0000899243-22-025708
4//SEC Filing

GOLD DANIEL P PHD 4

Accession 0000899243-22-025708

CIK 0001262104other
View on SEC.govCompany Profile

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 4:25 PM ET

Size

16.1 KB

Accession

0000899243-22-025708

Insider Transaction Report

Form 4
Period: 2022-07-05
MEI Pharma, Inc.MEIP
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-07-05+1,496,000→ 1,496,000 total
    Exercise: $0.54Exp: 2032-07-05→ Common Stock (1,496,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $4.33Exp: 2028-06-22→ Common Stock (380,000 underlying)
    380,000

  • Stock Option (Right to Buy)

    Exercise: $4.28Exp: 2028-07-12→ Common Stock (300,000 underlying)
    300,000

  • Stock Option (Right to Buy)

    Exercise: $2.52Exp: 2029-07-01→ Common Stock (675,000 underlying)
    675,000

  • Stock Option (Right to Buy)

    Exercise: $3.49Exp: 2030-07-02→ Common Stock (680,000 underlying)
    680,000

  • Stock Option (Right to Buy)

    Exercise: $1.57Exp: 2025-07-28→ Common Stock (275,500 underlying)
    275,500

  • Stock Option (Right to Buy)

    Exercise: $2.83Exp: 2027-07-06→ Common Stock (380,000 underlying)
    380,000

  • Stock Option (Right to Buy)

    Exercise: $2.95Exp: 2031-07-01→ Common Stock (855,000 underlying)
    855,000

  • Stock Option (Right to Buy)

    Exercise: $1.36Exp: 2026-07-29→ Common Stock (380,000 underlying)
    380,000
Footnotes (6)
  • [F1]One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.
  • [F2]One-quarter of such options vested on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
  • [F3]All of such options are presently exercisable.
  • [F4]One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
  • [F5]One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
  • [F6]One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

→
Entity typeother

Related Parties

1
  • filerCIK 0001288233

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:25 PM ET
Size
16.1 KB
View on SEC.gov